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Summary Control (C) or Thymoma (T) implanted male C57BL/6J mice received a basal diet containing
16.5% glucose (G) or fructose (F). Compared to the C-G group, the C-F mice consumed more food and less
water, and gained more weight. The blood glucose, insulin and triglyceride levels were higher in the C-F than
in the C-G mice. Thymoma implantation into the right flank caused a transient decrease in body weight
followed by a steady increase due to tumour growth. Tumours were detected earlier and tumour size was
greater in the T-F group than in the T-G mice. Tumour chemical composition was similar in both groups.
Blood analysis showed that the T mice had lower glucose and higher insulin and triglyceride levels than the C
group. Carcasses from the T groups contained more water and ash and less fat than their C counterparts, but
the type of sugar did not affect the body composition of the C or T groups. The results suggest that dietary
fructose may enhance the growth of tumour via its hyperinsulinaemic action.
Fructose consumption has increased significantly in the
western countries during the last years. High-fructose corn
syrups are widely used as sweeteners, and are promoted as a
healthy food additive useful for weight reduction, exercise
endurance and are recommended for diabetic patients. It has
been estimated that Americans consume as much as 70 g
fructose/d, which represents approximately 10% of the daily
caloric intake (Reiser, 1978).
Moderate levels of dietary fructose can produce undesir-
able changes in glucose metabolism of both normal and
hyperinsulinaemic subjects, causing an increase in fasting
blood glucose levels and gastric inhibitory peptide secretion
(Hallfrisch et al., 1983). Fructose feeding and to a lesser
extent, glucose feeding were shown to cause elevated plasma
insulin, glucose and triglycerides (Reiser et al., 1987; Zava-
roni et al., 1980, 1982; Sleder et al., 1980; Hallfrisch et al.,
1983a, b). Raised triglycerides levels were associated in a
number of cases with impaired insulin action (Hallfrisch et
al., 1983a, b; Zavaroni et al., 1982). Thornburn et al. (1989),
attributed this phenomenon to fructose rather than to glu-
cose consumption. The involvement of plasma glucose and
insulin in malignancies, mostly as enhancing factors, are by
now well documented (Pavelic & Slyjepcevic, 1978; Pavelic et
al., 1979; Yam et al., 1988; Yam et al., 1990a,b). Recently
Enzmann et al. (1989) reported that fructose administered in
the drinking water to N-nitrosomorpholine-treated rats led to
a higher incidence of hepatocellular carcinoma.
The objective of the present work was to compare the
effects of dietary glucose and fructose on the incidence and
development of Thymoma (an insulin-dependent tumour)
and on blood glucose, insulin and triglyceride levels in mice
with and without implanted Thymoma tumours.
Materials and methods
Animals, diets and management
C57BL/6J male mice (26-30 weeks old) were purchased from
Jackson Laboratories, Pearl Harbor, Maine, USA. They were
kept in filter-covered plastic cages (10 mice per cage) and fed
ad lib with a basal pelleted diet (Table I) containing either
16.5% glucose or fructose.
Sixty mice were fed the glucose (G) or the fructose (F)
diet. After 10 days, three cages (30 mice) from each dietary
treatment were selected at random and the animals were
injected in the right flank muscle with Thymoma tumour
cells. The 30 remaining mice in each dietary treatment were
kept as intact controls (C). The Thymoma cells, produced
according to Haran-Ghera et al. (1977), were provided by A.
Peled, Weizmann Institute of Science and maintained by
serial passage in the mice flanks. The tumour cell suspensions
were washed three times by centrifugation with phosphate
buffered saline (Gibco Ltd, Scotland). Cell viability was
ascertained by trypan blue exclusion. The number of
Thymoma cells injected was 1.5 x 106.
Body weight and food intake were recorded in all groups.
The presence of tumour in its early stage of development was
determined by palpation. Ten mice per dietary treatment
were sacrified by decapitation 23 days after implantation of
Thymoma cells, and blood was collected immediately. Con-
trol counterparts were sacrificed together with Thymoma
implanted groups. Blood was collected immediately and the
carcass was kept frozen at -200 for further chemical ana-
lyses.
Blood analyses
All analyses were carried out on three pooled samples of six
mice for each dietary treatment of control and tumour-
implanted mice. Part of the blood was transferred to pre-
cooled centrifuge tubes containing fluoride-oxalate and
centrifuged (1,500 r.p.m. 10min-'). Plasma glucose was
determined the same day by the glucose oxidase procedure
according to Pennock et al. (1973).
After coagulation of the blood (2 h, 50) and centrifugation,
the serum was collected and frozen. The insulin level was
Table I Composition of the diets
Ingredients g x kg-'
Corn starch 308
Defatted soya-bean meal (44% protein) 412
Soya-bean oil 40
Dicalcium phosphate 20
NaCl 5
Vitamins-microelements mixa 50
Glucose or fructose 165
aTo supply per kg ofdiet: vt. A, 26,000 IU; vit. D3, 4,000 IU; vit. E,
224 mg; vit. K, 90 mg; thiamin HCl, 65 mg; riboflavin, 30mg; niacin,
65 mg; pantothenic acid, 245 mg; pyridoxine, 20 mg; folic acid, 10mg;
B12, 0.004 mg; choline chloride, 2 g; para-aminobenzoic acid, 50 mg;
ethoxyquin, 124 mg; manganese, 65 mg; zinc, 10mg; iron, 20mg;
copper, 2mg; iodine, 1.3 mg; cobalt, 0.8 mg; selenium, 0.1 mg.
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determined in the serum by a double antibody radioimmuno-
assay, using '25I-labelled human insulin (Pharmacia Diag-
nostics AB, Uppsala Sweden). Triglycerides (TG) were
determined by an enzymatic procedure according to Fossati
and Principe (1982) (Triglycerides Enzymatiques PAP 1000,
Bio-Merieux, Charbonnieres-les-Bains, France).
a
26
25 Body and tumour composition
Body composition was determined on mouse carcasses stored
at -200 after blood collection and removal of the tumour.
The tumour was carefully freed of adhering muscle and
weighed. The carcass or tumour were freeze-dried to constant
weight, water content was calculated by difference. Total fat
was determined by ethyl ether extraction of the desiccated
material with a Soxhlet apparatus. After ash determination,
protein was calculated by difference:
Protein = Tissue weight-(water + ash + ether extract)
Body composition was determined for individual mice (ten
mice per type of tumour and dietary regime), while tumour
composition was determined in three pooled samples from
each dietary treatment.
Statistical analysis
Data were analysed by one-way analysis of variance. Differ-
ences between treatment means were assessed by Duncan's
multiple range test (1955).
Results
Food intake, water intake andbody weight
Food intake and body weight of the non-implanted mice
serving as controls were affected significantly by the type of
sugar. The F mice gained more weight and consumed more
food as compared to the G mice whose body weight and
food consumption were constant throughout the experiment-
al period (Figure la and b). Water intake was highest at the
start of the experiment, when the sugar enriched diets were
offered, and decreased gradually thereafter (Figure 1c). In
spite of the higher food intake, water consumption was lower
in the F mice.
Tumour implantation was accompanied by a transient
depression in food intake which was more pronounced in the
F-fed mice than in the G group.
No consistent difference in water intake was observed
between the tumour-bearing mice fed glucose and those
receiving fructose, the water consumption in both groups
being quite similar to that of the G control group.
The mean body weight of the tumour-bearing mice increas-
ed dramatically from day 10 after tumour implantation
(Figure 2), while the body weights of the implanted mice in
which no tumours were detected were similar to those of the
non-implanted controls.
Tumour incidence and weight
Tumours were detected in F fed mice earlier than in G fed
ones (Figure 2). On day 15 after implantation, tumours were
found in 23 mice of the F fed group as compared to 17 mice
among the G fed animals. This difference subsisted till the
end of the experimental period. Bigger tumours were observ-
ed in the F fed mice (Table II) which accounted for the
higher body weight of this group.
Proximate composition oftumour (Table II) and carcass
(Table III)
There were no differences in tumour contents of water, fat
and ash between the two dietary groups.
The water content was much higher in the thymoma-
bearing mice than in the controls, fat concentration was
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Figure 1 Mean body weights, food intake and water intake per
mouse of intact or tumour implanted mice receiving glucose
(U-U) or fructose (+--+) and of tumour implanted mice
receiving glucose (*....*) or fructose (0--0). Results for both
dietary treatments up to the day of implantation were pooled.
Vertical bars stand for the s.e.m.
lower by 40-50% and protein by 25%. The diet did not
affect the body composition ofthe controls or the Thymoma-
bearing mice.
Blood components (Table IV)
Glucose and insulin levels were higher in the F fed control
mice than in the G fed controls. Tumour implantation result-
ed in a lowered glucose level, while insulin levels increased
dramatically. The response to tumour implantation was more
pronounced in the F group than in G fed mice.
Triglycerides were higher in F group than in the G group,
both in the implanted and control mice, but this diet effect
was not statistically significant.
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Figure 2 Mean body weights ofimplanted mice which developed
tumours. Figures shown on the upper two curves indicate the
tumours detected in 30 mice. Tumour incidence and body weights
of tumour-bearing mice were significantly higher for the fructose
group than the the glucose-fed animals (paired t-test, P<0.01
and P<0.05 respectively). Vertical bars stand for the s.e.m.
Glucose diet (+---+); fructose diet (E---E).
Table II Tumour weighta and compositionb at autopsy
Diet Glucose Fructose S.E.M.
Tumour weight (g) 1.33 2.26 0.12*
Water (%) 7.05 6.89 0.38 NS
Fat (%) 2.52 2.07 0.20 NS
Ash (%) 1.58 1.70 0.08 NS
aMean values from 10-12 observations. bMean values from three
pooled samples from 3-4 mice each. *Statistically significant
difference, P <0.05. NS indicates that the difference is not
statistically significant.
Table III Carcass weight and composition of mice at autopsy
Control Thymoma-Implanted'
Glucose Fructose Glucose Fructose S.E.M.
Weight (g) 23.2a 24.9a 24.Oa 22.4b 0.29
Water (%) 57.9b 60.4b 69.1a 69.1a 3.5
Fat (%) boa 9.1la 6.12b 4.95b 0.76
Ash (%) 3.18c 3.16c 3.61a 4.33a 0.23
Protein (%) 27.3a 28.9a 21.6b 21.4b 0.95
Mean values from ten mice for control and tumour-implanted
mice. Values within rows with different superscripts differ to a
statistically significant degree, P <0.05. 'Carcass without tumour.
Dietary fructose can produce changes in glucose and/or
insulin metabolism (see Introduction). Therefore, it was of
interest to verify its effects on mice implanted with an insu-
lin-dependent tumour such as Thymoma, in comparison with
animals receiving glucose.
Implanted Thymoma mice had low glucose and high insu-
lin and triglyceride levels, which constitutes a characteristic
feature of tumour-bearing animals, and was reported in our
previous studies (Yam et al., 1990a,b). It is of interest that
the blood insulin level in tumour-bearing mice was especially
high in the group receiving fructose. Dietary fructose also
had hyperinsulinaemic effect in non-implanted control mice,
more so than glucose, when compared to mice of the same
strain receiving a sugar-free diet (Yam et al., 1990a, b).
More importantly, dietary fructose enhanced the Thymoma
growth, as seen from the earlier detection and larger size of
the tumours. Tumour incidence appeared to be higher in the
fructose group than in the glucose-fed animals (83% vs
57%), but this difference is of doubtful biological signi-
ficance, because of the limited data on tumour take rate:
previous experiments have shown that the take rate of the
tumour in mice receiving the conventional pelleted diet is
about 60%, i.e., similar to the glucose-fed animals.
The question therefore arises if and to what extent the
increased tumour expression in the fructose fed mice may be
related to insulin metabolism. There is some evidence that
tumorigenesis in humans and laboratory animals is enhanced
by elevated energy intake (Kritchevsky & Kleerfeld, 1986;
Pariza, 1986; Graham, 1986; Kleerfield et al., 1987), high
consumption of mono and disaccharides (Risch et al., 1985),
starch (LaVecchia et al., 1987), total fat and saturated fatty
acids (Tonioli et al., 1989) and omega-6 polyunsaturated
fatty acids (Carroll, 1980; Hubbard & Erickson, 1987; Roe-
buck et al., 1981).
All of these dietary factors are characterised by their
enhancing effect on insulin secretion or by their interference
with insulin metabolism (Hollenbeck & Reaven, 1987; Green-
berger et al., 1968; Montague & Taylor, 1968; Sanbar &
Martin, 1967; Linscheer et al., 1967; Lardinois et al., 1987).
Hyperinsulinaemia is sometimes accompanied by glucose
intolerance (Hartog et al., 1987) because of down-regulation
of insulin receptors. This process is absent in tumour cells
(Mountjoy et al., 1987), and may be advantageous to these
cells, especially in the case of insulin-dependent tumours.
It was reported by Enzmann et al. (1989), that feeding
fructose caused a higher incidence of hepatocarcinoma in
N-nitroso-morpholine-treated rats. This higher incidence was
accompanied by an increase in hepatic glucose-6-phosphate
and in the activity ofglucose-6-phosphate dehydrogenase and
by an excessive deposition of glycogen in the preneoplastic
liver lesions. Unfortunately the insulin status was not ascer-
tained in these rats. There too, this hormone may constitute
a link between dietary fructose and tumour development.
It is concluded that high dietary fructose may enhance the
incidence and growth of implanted or chemically induced
murine tumours. The implications of the increasing fructose
consumption referred to in the introduction deserve con-
sideration in the context of human cancer.
Table IV Blood plasma or serum compositon
Control Thymoma-Implanted
Diet Glucose Fructose Glucose Fructose S.E.M.
Glucose
mgx(lOOml-') plasma 145b 170a 83d 58c 3.6
Insulin
iLUxml-' serum 3.2d 35.3c 56.3b 78.0a 2.3
Triglycerides
mgx(l00ml-') serum 180b 234b 313a 348a 13.9
Measurements were carried out on three pooled samples of six mice each for
each dietary treatment of control and tumour-implanted mice. Values within rows
with different superscripts differ to a statistically significant degree, P <0.05.
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